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Abstract: Objective: There is paucity of studies on the association between pulse pressure and the
development of dementia, although this association has already been established. This study aimed
at investigating the association between pulse pressure and the onset of dementia. Methods: We used
the South Korean National Health Insurance Service claims cohort data to select 149,663 patients
without dementia aged ≥60 years. We calculated adjusted hazard ratios (HRs) and 95% confidence
intervals (CIs) for dementia using Cox proportional hazard models according to a pulse pressure
classification (<50, 50–59, 60–69, 70–79, 80–89, or 90+). Results: Compared to women with pulse
pressure <50, those with pulse pressures of 50–59, 60–69, and 90+ had higher HRs for dementia
(1.14, 1.22, and 1.03, respectively). These associations were particularly strong in those on Medicaid
insurance and from rural regions. However, there were no statistically significant results among men.
Conclusions: A higher pulse pressure was associated with an elevated risk of dementia in women
aged >60 years, particularly those on Medicaid and from rural regions, possibly due to their inability
to access hypertension and other medical treatment. The establishment of dementia indicators will
help to guide future health policies for the prevention of dementia.
Keywords: pulse pressure; dementia; elderly; women; men
1. Introduction
Dementia is a major neuropsychiatric disorder, and is the fifth most common cause of death
worldwide. Its prevalence has increased rapidly, leading to a high economic burden as a result of the
growing social burden and costs related to the treatment to patients and their families [1]. Therefore,
the early identification of factors that increase the risk of dementia is a critical task in terms of disease
prevention, management, and policymaking [2]. For the early prevention of the onset of dementia,
previous studies have identified several risk factors such as social, demographic, genetic, physical, and
mental health factors [3–5].
Blood pressure is known to be an important indicator for predicting cardiovascular disease [6].
However, it is also recognized in the literature as a risk factor for dementia [7–9]. Elevated blood
pressure likely to increase the risk for dementia by causing small-vessel disease and white-matter
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lesions [7]. A previous study found that middle-aged men with high blood pressure or hypertension
had a higher risk for late age dementia than others who were treated [8]. One study, on the other hand,
said that low blood pressure may be a complication of the dementia process, particularly Alzheimer’s
disease [9].
Previous studies on hypertension have mainly focused on diastolic blood pressure in cognitive
function and dementia and in the investigation of the relationship between a high blood pressure and
the onset of dementia [10–12]. The Whitehall II cohort study found that 130 mmHg or above systolic
blood pressure at age 50 is related to increased risk for dementia in individuals free of cardiovascular
disease [10]. In contrast, another study showed that low diastolic pressure may be associated with a
higher risk of the onset of dementia in the elderly, i.e., over age 75, due to cerebral hypoperfusion [11].
A systolic hypertension trial in Europe also found new evidence that blood pressure lowering therapy
initiated with long-acting dihydropyridine protects against dementia in older patients with systolic
hypertension [12]. High blood pressure is also strongly associated with a decline in cognitive function
among the elderly [13,14]. One meta-analysis study found that hypertension has adverse effects
on cognition, can alter cerebral vasculature integrity, and is associated with the pathogenesis of
dementia [13]. In addition, people with high blood pressure were found to be likely to experience
a cognitive decline in a relatively short time period; the risk is highest in untreated hypertensive
patients [14].
While systolic and diastolic blood pressure have been reported as indicators of the onset of
dementia in some studies, there are no consistent results regarding the relationship between pulse
pressure and dementia [15–18]. Previous studies found that higher pulse pressure was an indicator that
pulse pressure is associated with increased risk of dementia [15–17]. One cohort study showed that
higher pulse pressure due to artery stiffness and severe atherosclerosis may be related to increased risk
of Alzheimer disease and dementia in old adults [15]. A trial on hypertension in the very elderly found
that wider pulse pressure may be an indicator of an increased risk of dementia; notably, they focused
on the association between diastolic blood pressure and dementia [16]. Moreover, one longitudinal
study revealed that increasing the level of pulse pressure and pulse wave velocity, which are markers
of arterial stiffness, was related to the onset of dementia [17]. On the other hand, Freitag’s team
showed that there is no association between pulse pressure and incidence of dementia [18]. Given
these inconsistencies, this study investigated the association between pulse pressure and the onset
of dementia.
2. Methods
2.1. Data
This study used data from the South Korean National Health Insurance Service-Health Screening
Cohort (NHIS-HEALS) database. This dataset included information gathered on approximately 515,000
patients between 2002 and 2013 and represents a random sample of 10% of the patient cohort stratified
according to age, sex, health insurance type, income level, individual total medical costs, and clinical
test results. The data also included a list of diagnoses according to the International Classification of
Diseases version 10 (ICD-10), medical costs claimed, prescribed drugs, and medical history [19].
2.2. Study Population
We conducted a cohort study using a random sample of national health insurance service claims
data. We excluded patients diagnosed with dementia between 2002 and 2003. We also excluded
patients with missing values for the covariates. From the 2004 to 2010 claims data, we selected patients
without preonset of dementia who were aged ≥60. This resulted in a cohort of 149,663 patients.
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2.3. Variables
The onset of dementia was defined by the ICD-10 codes G30, G31.1, G31.9, G31.8, F00, F03,
and F05.1. Blood pressure was measured using an automated sphygmomanometer during routine health
screenings conducted every two years as part of a national health screening program. Pulse pressure
was defined as follows: systolic blood pressure–diastolic blood pressure. This information was
obtained from the NHIS-HEALS database. Pulse pressures were classified into six groups, namely,
≤50, 50–59, 60–69, 70–79, 80–89, and ≥90.
Demographics and socioeconomic factors such as age, household income, and type of insurance
were obtained from the NHIS-HEALS database. Patients were stratified into three groups based on
their age as 60–69, 70–79, and ≥80 years. Patients were further stratified into quintiles based on their
household income. In Korea, health care contributions are calculated according to household income.
Patients who paid 0% of health insurance premiums were classified as Medicaid, those who paid up
to 20% were classified as low income, those who paid 21–80% were classified as middle income, and
those who paid over 80% of the premium were classified as high income.
We used the Charlson comorbidity index (CCI) to measure comorbid conditions. The CCI assesses
19 diseases: myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular
disease, dementia, chronic pulmonary disease, rheumatic disease, peptic ulcer disease, mild liver
disease, diabetes without chronic complication, diabetes with chronic complication, hemiplegia or
paraplegia, renal disease, any malignancy (including lymphoma and leukemia, except malignant
neoplasm of the skin), moderate or severe liver disease, metastatic solid tumor, and AIDS/HIV. The CCI
was calculated 1 year before patients were enrolled in the study [20]. The duration of treatment
for hypertension (alpha- or beta-blockers, angiotensin converting enzyme inhibitors, angiotensin
II receptor antagonists, diuretics, and calcium channel blockers), diabetes mellitus (sulfonylureas,
metformin, thiazolidinedione, and alpha-glucosidase inhibitors), and dyslipidemia (any statins, fibrate,
and omega 3 fatty acids) was determined using data on the duration of medications during the
follow-up period. Hyperglycemia was defined as fasting blood glucose >110 mg/dL, measured in a
clinical laboratory.
2.4. Statistical Analysis
We used descriptive statistics for the baseline characteristics of the study population. Differences
between groups were determined using a chi-square test, t-test, and analysis of variance. Cumulative rates
and incidence curves were constructed and compared using the Gray’s test for equality of cumulative
incidence functions. Thereafter, we estimated the adjusted hazard ratios (HRs) and 95% confidence
intervals (CIs) for dementia by applying a Cox proportional hazard regression analysis according to sex.
In this model, we adjusted for systolic and diastolic blood pressure; age; region; household income; type
of insurance body mass index (BMI); disability status; charlson comorbidity index (CCI); duration of
treatment for hypertension, diabetes mellitus, dyslipidemia, and hyperglycemia; hospital classification;
and year. Lastly, we conducted a subgroup analysis according to the type of insurance and region.
All statistical analyses were conducted with SAS version 9.4 (SAS institute, Inc., Cary, NC, USA) and R
version 3.6 with package “cmprsk” (R Core Team (2018). R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/).
Statistical significance was set at p < 0.05.
3. Results
Table 1 shows baseline demographic characteristics of the study population. Among 149,663
patients, 73,272 were men and 76,391 were women. The rates of pulse pressure in the six groups
(<50, 50–59, 60–69, 70–79, 80–89, and ≥90) were 1.6%, 1.8%, 1.9%, 1.9%, 2.2%, and 2.3%, respectively,
in men and 2.5%, 2.7%, 3.1%, 3.1%, 3.5%, and 4.5%, respectively, in women with the onset of dementia.
The total number of men and women with dementia was 1.8% and 2.7%, respectively. According to
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age groups (60–69, 70–79, and ≥80 years), the percentages of participants were 70.0% (n = 51,303),
27.7% (n = 20,051), and 2.6% (n = 1918) in men, 67.3% (n = 51,449), 29.8% (n = 22,764), 2.9% (n = 2178)
in women respectively.
Figure 1 shows the cumulative incidence function of dementia using the Gray’s test for pulse
pressure. The cumulative incidence curve for the group of patients with pulse pressures of ≥90 was
lower than that of other groups in both men (p = 0.01) and women (p < 0.0001).
Figure 1. The cumulative incidence function of dementia using the Gray’s test for pulse pressure.
Table 2 shows the adjusted HRs for dementia using Cox proportional hazard models for pulse
pressure and covariates. Among women, the 50–59 (HR: 1.14, 95% CI: 1.04–1.25), 60–69 (HR: 1.22,
95% CI: 1.07–1.39), and ≥90 (HR: 1.03, 95% CI: 1.03–1.80) pulse pressure quartiles showed higher HRs
for the incidence of dementia than the ≤50 quartile. However, there were no statistically significant
differences for pulse pressure in men.
Table 1. Baseline characteristics of the study population from 2004 to 2010.
Variables Total
The Number and Incidence of Dementia
Men Women p–Value
N % N %
Pulse pressure 0.0493
<50 57,608 944 1.6 1428 2.5
50–59 49,610 872 1.8 1344 2.7
60–69 27,046 515 1.9 831 3.1
70–79 10,595 201 1.9 329 3.1
80–89 3367 74 2.2 117 3.5
≥90 1437 33 2.3 64 4.5
Systolic blood pressure 0.5369
<120 50,755 852 1.7 1403 2.8
120–129 11,917 177 1.5 270 2.3
130–139 39,039 687 1.8 1007 2.6
>140 47,952 923 1.9 1433 3.0
Diastolic blood pressure 0.2388
<60 2046 31 1.5 62 3.0
61–80 58,020 1005 1.7 1604 2.8
81–90 55,127 955 1.7 1486 2.7
>90 34,470 648 1.9 961 2.8
Age < 0.0001
60–69 102,752 1269 1.2 2001 1.9
70–79 42,815 1212 2.8 1873 4.4
80+ 4096 158 3.9 239 5.8
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Table 1. Cont.
Region 0.0135
Capital area 46,295 684 1.5 894 1.9
Metropolitan area 34,280 553 1.6 832 2.4
Rural 69,088 1402 2.0 2387 3.5
Household income 0.0099
1st quintile 29,273 528 1.8 941 3.2
2nd quintile 22,894 444 1.9 628 2.7
3rd quintile 22,747 374 1.6 520 2.3
4th quintile 30,458 493 1.6 733 2.4
5th quintile 44,291 800 1.8 1291 2.9
Types of insurance 0.0003
NHI, self–employed insured 148,839 2622 1.8 4055 2.7
Medical aid 824 17 2.1 58 7.0
BMI <0.0001
Underweight (<18.5) 70,488 125 0.2 166 0.2
Normal (18.5–22.9) 44,447 1141 2.6 1401 3.2
Overweight (23–24.9) 21,981 681 3.1 1024 4.7
Obesity (≥25) 12,747 692 5.4 1522 11.9
Disability 0.0361
Yes 2419 112 4.6 64 2.6
No 147,244 2527 1.7 4049 2.7
CCI 0.0210
0 70,488 1162 1.6 1529 2.2
1 44,447 786 1.8 1379 3.1
2 21,981 390 1.8 782 3.6
3+ 12,747 301 2.4 423 3.3
Duration of treatment for hypertension 0.0937
0 45,413 630 1.4 709 1.6
1–365 days 71,503 1193 1.7 2208 3.1
366–730 days 21,096 506 2.4 824 3.9
>730 days 11,651 310 2.7 372 3.2
Duration of treatment for diabetes
mellitus 1.0000
0 116,896 1982 1.7 3038 2.6
1–365 days 20,851 345 1.7 635 3.0
366–730 days 7303 188 2.6 287 3.9
>730 days 4613 124 2.7 153 3.3
Duration of treatment for dyslipidemia 0.2083
0 89,894 1644 1.8 2089 2.3
1–365 days 36,571 480 1.3 1150 3.1
366–730 days 14,350 294 2.0 579 4.0
>730 days 8848 221 2.5 295 3.3
Hyperglycemia 0.1142
No 116,463 1998 1.7 3203 2.8
Yes 33,200 641 1.9 910 2.7
Hospital classification 0.0298
General hospital 39,371 680 1.7 971 2.5
Hospital 34,314 653 1.9 1,068 3.1
Clinic 75,978 1306 1.7 2074 2.7
Year 0.0540
2004 46,217 1033 2.2 1429 3.1
2005 50,882 990 1.9 1558 3.1
2006 21,264 348 1.6 586 2.8
2007 13,830 176 1.3 330 2.4
2008 7331 59 0.8 130 1.8
2009 6808 28 0.4 67 1.0
2010 3331 5 0.2 13 0.4
Total 149,663 2639 1.8 4113 2.7
Note: BMI, Body mass index; CCI, Charlson comorbidity index; NHI, National health insurance.
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Table 2. Adjusted hazard ratio for dementia using Cox proportional hazard models.
Variables
Hazard Ratio of Dementia
Men Women
HRs 95% CIs HRs 95% CIs
Pulse pressure
<50 1.00 1.00
50–59 1.00 (0.89–1.13) 1.14 (1.04–1.25)
60–69 0.99 (0.84–1.16) 1.22 (1.07–1.39)
70–79 0.91 (0.73–1.12) 1.14 (0.96–1.35)
80–89 1.03 (0.78–1.36) 1.15 (0.92–1.44)
≥90 1.03 (0.70–1.50) 1.37 (1.03–1.80)
Systolic blood pressure
<120 1.00 1.00
120–129 0.91 (0.77–1.08) 0.85 (0.74–0.98)
130–139 1.00 (0.87–1.15) 0.83 (0.74–0.93)
>140 1.02 (0.83–1.24) 0.83 (0.70–0.97)
Diastolic blood pressure
<60 1.00 1.00
61–80 1.13 (0.79–1.62) 1.08 (0.84–1.40)
81–90 1.02 (0.71–1.48) 1.13 (0.86–1.47)
>90 1.00 (0.68–1.48) 1.14 (0.86–1.51)
Age
60 – 69 1.00 1.00
70–79 2.33 (2.14–2.53) 2.11 (1.98–2.25)
80+ 3.50 (2.95–4.16) 3.49 (3.03–4.01)
Region
Capital area 0.73 (0.67–0.81) 0.71 (0.65–0.77)
Metropolitan area 0.82 (0.75–0.91) 0.85 (0.78–0.92)
Rural 1.00 1.00
Household income
1st quintile 1.08 (0.96–1.21) 1.04 (0.95–1.13)
2nd quintile 1.09 (0.97–1.23) 0.97 (0.88–1.07)
3rd quintile 1.00 (0.88–1.13) 0.87 (0.78–0.96)
4th quintile 0.97 (0.86–1.08) 0.90 (0.82–0.99)
5th quintile 1.00 1.00
Types of insurance
NHI, self–employed insured 0.91 (0.56–1.47) 0.59 (0.45–0.77)
Medical aid 1.00 1.00
BMI
Underweight (<18.5) 0.85 (0.70–1.02) 1.11 (0.94–1.30)
Normal (18.5–22.9) 1.00 1.00
Overweight (23–24.9) 0.88 (0.80–0.97) 0.93 (0.85–1.00)
Obesity (≥25) 0.83 (0.76–0.92) 0.87 (0.80–0.93)
Disability
Yes 1.41 (1.16–1.70) 1.23 (0.96–1.58)
No 1.00 1.00
CCI
0 1.00 1.00
1 1.12 (1.02–1.22) 1.16 (1.08–1.25)
2 1.10 (0.98–1.23) 1.28 (1.17–1.39)
3+ 1.26 (1.11–1.43) 1.27 (1.13–1.41)
Duration of treatment for hypertension
0 1.00 1.00
1–365 days 1.40 (1.26–1.55) 1.29 (1.18–1.41)
366–730 days 1.85 (1.59–2.16) 1.70 (1.48–1.95)
>730 days 1.94 (1.57–2.41) 1.50 (1.21–1.85)
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Table 2. Cont.
Duration of treatment for diabetes mellitus
0 1.00 1.00
1–365 days 1.02 (0.89–1.16) 1.24 (1.12–1.36)
366–730 days 1.21 (1.01–1.46) 1.22 (1.05–1.41)
>730 days 1.09 (0.86–1.37) 1.21 (0.99–1.49)
Duration of treatment for dyslipidemia
0 1.00 1.00
1–365 days 1.14 (1.02–1.27) 1.04 (0.96–1.13)
366–730 days 1.08 (0.91–1.28) 1.10 (0.96–1.26)
>730 days 1.22 (0.97–1.53) 1.09 (0.87–1.36)
Hyperglycemia
No 1.00 1.00
Yes 0.97 (0.88–1.07) 0.94 (0.87–1.02)
Hospital classification
General hospital 0.98 (0.89–1.08) 1.01 (0.93–1.09)
Hospital 1.05 (0.96–1.16) 1.14 (1.05–1.22)
Clinic 1.00 1.00
Year
2004 1.00 1.00
2005 1.15 (1.04–1.26) 1.06 (0.98–1.15)
2006 1.48 (1.30–1.69) 1.22 (1.10–1.35)
2007 1.60 (1.35–1.90) 1.43 (1.26–1.62)
2008 1.61 (1.22–2.11) 1.79 (1.48–2.16)
2009 1.62 (1.10–2.39) 1.84 (1.43–2.38)
2010 1.84 (0.76–4.48) 2.06 (1.18–3.59)
Note: BMI, Body mass index; CCI, Charlson comorbidity index; NHI, National health insurance.
Table 3 shows the adjusted HRs for the subgroup analysis. For women in the Medicaid group, the
50–59 (HR: 5.71, 95% CI: 2.02–16.12), 60–69 (HR: 9.16, 95% CI: 2.31–36.36), 70–79 (HR: 17.53, 95% CI:
3.23–95.12), 80–89 (HR: 19.91, 95% CI: 3.59–110.56), and ≥90 (HR: 86.80, 95% CI: 11.76–1.640.69) pulse
pressure quartiles were associated with higher HRs for the incidence of dementia than the ≤50 quartile.
However, there were no statistically significant results for men. For women who lived in the capital area,
the 50–59 and 60–69 pulse pressure quartile groups had higher HRs than the ≤50 group. For women
who lived in rural areas, only the ≥90 pulse pressure group had a higher HR than the ≤50 group.
Table 3. Adjusted hazard ratio for incidence of dementia according to subgroups using Cox proportional
hazard models *.
Subgroups Pulse Pressure
Hazard Ratio of Dementia
Men Women
HRs 95% CIs HRs 95% CIs
Types of insurance
NHI, self–employed insured <50 1.00 1.00
50–59 1.00 (0.89–1.13) 1.12 (1.02–1.24)
60–69 0.98 (0.84–1.16) 1.20 (1.05–1.37)
70–79 0.90 (0.73–1.12) 1.11 (0.93–1.31)
80–89 1.00 (0.76–1.33) 1.11 (0.88–1.39)
≥90 1.03 (0.71–1.51) 1.28 (0.97–1.71)
Medical aid <50 1.00 1.00
50–59 0.81 (0.12–5.55) 5.71 (2.02–16.12)
60–69 1.07 (0.06–19.99) 9.16 (2.31–36.36)
70–79 4.12 (0.11–151.70) 17.53 (3.23–95.12)
80–89 7.88 (0.31–199.00) 19.91 (3.59–110.56)
≥90 86.80 (11.76–640.69)
Note: NHI, National health insurance; Analysis was adjusted for the following covariates: systolic blood pressure,
diastolic blood pressure, age, region, household income, BMI, CCI, duration of treatment for hypertension, diabetes
mellitus, dyslipidemia, hyperglycemia, hospital classification, and year.
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4. Discussion
This study examined the association between pulse pressure and the onset of dementia among
men and women. After controlling for several covariates, elderly women with a high pulse pressure
were shown to have a significantly higher rate of onset of dementia than those with a low pulse
pressure. Moreover, these associations were strong among women in the Medicaid group who lived in
rural areas.
The results from this study showed that high pulse pressure levels were associated with the
risk of developing dementia. These results are similar to those from previous studies that reported
the association between an elevated pulse pressure and decreased cognitive function in community
members aged 55–64 years using data from the Framingham Offspring Cohort Study conducted to
identify risk factors for cardiovascular disease during the 1998–2009 period [21]. In addition, previous
studies have demonstrated an association between an increased pulse pressure and pulse rate and
decreased cognitive function [16,22]. The association between high pulse pressure levels and an
increased risk of developing dementia may be explained by the traditional belief that dementia is a
cerebral neurodegenerative disease that occurs as a result of the accumulation of β-amyloid, as well
as the method of reporting and interpreting it as a result of cerebral white matter changes due to
vascular diseases [23]. On the other hand, more recent studies offer evidence for the role of the
disconnection hypothesis of Alzheimer’s disease due to white matter lesions of the frontal-prefrontal
cortical-subcortical circuits accounting for cognition and mood-affect [24–28]. These findings have
been supported using transcranial magnetic stimulation and transcranial Doppler sonography.
Another possibility is that pulse pressure has a high positive correlation with plasma B-type
natriuretic peptide (BNP), and high BNP levels have a high correlation with microvascular damage.
Therefore, damage and disease in the microvessels of the cerebrum cause the denaturation of blood
vessels. These negative changes in the blood vessels destroy the function of the blood–brain barrier,
thereby increasing the accumulation of β-amyloid due to increased permeability and protein runoff in
the cerebral cortex [29–33].
In contrast, atherosclerosis, a vascular disease, of the blood vessels leads to a rise in the blood
pressure. Vascular rigidity and atherosclerosis increase the risk of dementia, indicating that vascular
diseases impose a similar risk as cardiovascular disease [34–36]. It has also been reported that blood
vessel-rigidity can cause microvascular disorders and diseases in the brain [37]. Rigidity reduces the
absorption of waves in the arteries, leading to an increased pressure in blood flow to the capillaries of the
brain. These disorders of the cerebral blood vessels can increase the white matter in the brain, which is
common in patients with dementia [37]. Therefore, pulse pressure and the range of white matter lesions
in the brain and their severity are highly relevant. White matter abnormalities are also highly related
to cognitive impairment [38–42]. It can be inferred that high pulse pressure levels are associated with
increased brain white matter lesions and the occurrence of dementia through microvessel disorders
in the cerebrum [38–42]. Therefore, those diseases are likely to be synergistic effects to developing
dementia [43]. Moreover, one study found the possibility that pulse pressure may be also related
to increased cerebrospinal fluid and phosphorylated-tau in normal elderly [44]. It is possible that
pulsatile hemodynamics may be associated with amyloidosis and tau-related neurodegeneration [44].
In this study, the association between a high pulse pressure and the high risk of developing
dementia was evident only in women. This observation was similar to that of previous studies
conducted in elderly [16,45]. One study found that lower pulse pressure was 1.4 times more common
among women than men [45]. This study proposed that the association between pulse pressure
and dementia is due to artery stiffness and severe atherosclerosis, and poor cerebral perfusion [45].
Another study also found that women were 1.5 times more likely than men to have a probability
of Alzheimer’s disease and severity of cognitive impairment [16]. Although we could not find the
underlying mechanisms for the difference between sexes, we guess that it is possible that women
often receive less education, and are subject to the stronger effect of Apolipoprotein E, and bilateral
oophorectomy compared to men [46]. In contrast, depressive symptoms may affect the increasing
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risk of dementia in elderly women. Many studies have found that women are more likely to be with
depressive symptoms than men [47–50]. This may be due to differences in genetic influence and the
social role of women, e.g., as caregivers, living alone, and social support [47–50]. Depressive symptoms
could be related to dementia. A previous study mentioned that vascular depression may also be related
to white matter lesions due to vascular damage to frontal subcortical circuits [38]. Therefore, these
factors may have led to the high incidence of dementia in elderly women. However, we could not
take into account the proportion of depressive symptoms among both men and women at baseline,
which may have affected the results. Despite these studies, medical or biological explanations for
the elevated risk of dementia in women remain controversial due to a paucity of evidence; therefore,
further research is needed.
Our study had several limitations. First, because the follow-up period from the medical examination
to the onset of dementia took place over a 10-year-period, it is possible that we under- or over- estimated
the link between the measurement of blood pressure and fasting blood glucose depending on the time of
the examination or the current health condition of the patient. In addition, we could not include patients
who did not undergo blood pressure testing or a health check-up every 2 years. However, blood pressure
was measured at a clinical laboratory; therefore, the measurements were reliable. Second, although
we used the ICD-10 codes for the diagnosis of dementia, this might have been overestimated due to
up-coding errors or misclassification biases associated with the claims data. Therefore, the results should
be interpreted with caution. Finally, there is an added potential for the overestimation or undervaluation
of statistical results due to unadjusted confounding factors.
5. Conclusions
Although our findings need further confirmation, we believe that there is an association between
pulse pressure and the incidence of dementia. A higher pulse blood pressure is associated with an
elevated risk of dementia in individuals aged >60 years, but only in women. Furthermore, the results
from the subgroup analysis revealed that elderly women with Medicaid living in rural areas should be
targeted so that interventions aimed at preventing dementia can be implemented among this population.
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